EP3056194A1 - Épaississant à faible pouvoir filant et substance cosmétique mélangée avec ledit épaississant - Google Patents
Épaississant à faible pouvoir filant et substance cosmétique mélangée avec ledit épaississant Download PDFInfo
- Publication number
- EP3056194A1 EP3056194A1 EP13895394.8A EP13895394A EP3056194A1 EP 3056194 A1 EP3056194 A1 EP 3056194A1 EP 13895394 A EP13895394 A EP 13895394A EP 3056194 A1 EP3056194 A1 EP 3056194A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- molecular weight
- stringiness
- million
- salt
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 239000002562 thickening agent Substances 0.000 title claims abstract description 28
- 239000000463 material Substances 0.000 title description 3
- 150000003839 salts Chemical class 0.000 claims abstract description 58
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 42
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 39
- -1 i.e. Substances 0.000 claims abstract description 26
- 229920000642 polymer Polymers 0.000 claims description 43
- 239000002994 raw material Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 abstract description 91
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 91
- 229910052708 sodium Inorganic materials 0.000 description 91
- 239000011734 sodium Substances 0.000 description 91
- 239000000203 mixture Substances 0.000 description 89
- 238000012360 testing method Methods 0.000 description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 238000006116 polymerization reaction Methods 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 21
- 238000005227 gel permeation chromatography Methods 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 20
- 239000000243 solution Substances 0.000 description 16
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 229920001059 synthetic polymer Polymers 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 14
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 13
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 13
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 238000010526 radical polymerization reaction Methods 0.000 description 12
- 239000000178 monomer Substances 0.000 description 10
- 238000004108 freeze drying Methods 0.000 description 9
- 229920002521 macromolecule Polymers 0.000 description 9
- 159000000000 sodium salts Chemical class 0.000 description 9
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 7
- 239000012300 argon atmosphere Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 238000011045 prefiltration Methods 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- 229920005615 natural polymer Polymers 0.000 description 5
- 230000003472 neutralizing effect Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000027756 respiratory electron transport chain Effects 0.000 description 4
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000012986 chain transfer agent Substances 0.000 description 3
- 239000013065 commercial product Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 235000019983 sodium metaphosphate Nutrition 0.000 description 3
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 2
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000010550 living polymerization reaction Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical class CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 229960003001 adenosine triphosphate disodium Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- YOQLRQUGJROXRV-UHFFFAOYSA-N benzenecarbodithioic acid;4-cyanopentanoic acid Chemical compound N#CC(C)CCC(O)=O.SC(=S)C1=CC=CC=C1 YOQLRQUGJROXRV-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000010551 living anionic polymerization reaction Methods 0.000 description 1
- 238000010552 living cationic polymerization reaction Methods 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- SINFYWWJOCXYFD-UHFFFAOYSA-N methoxymethyl prop-2-enoate Chemical compound COCOC(=O)C=C SINFYWWJOCXYFD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- JJYKJUXBWFATTE-UHFFFAOYSA-N mosher's acid Chemical compound COC(C(O)=O)(C(F)(F)F)C1=CC=CC=C1 JJYKJUXBWFATTE-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/04—Acids; Metal salts or ammonium salts thereof
- C08F120/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/52—Amides or imides
- C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F120/58—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-acryloyl morpholine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/44—Preparation of metal salts or ammonium salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Definitions
- the present invention relates to a less stringiness thickener suitable for cosmetics and a cosmetic admixed with the said thickeners.
- various kinds of thickeners are blended in cosmetics for the realization of a viscosity suitable for use, the improvement in the feeling in use, and the stabilization of emulsion systems.
- Many of them are water-soluble polymer compounds and classified, depending upon their origins, into natural polymers (xanthan gum, hyaluronic acid, etc.), semi-synthetic polymers in which functional groups are added to natural polymers by synthesis reactions, and synthetic polymers.
- natural polymer compounds have issues such as supply stability and quality stability (lot-dependent viscosity variation, contamination by microorganisms, etc.); thus the demand for synthetic polymer compounds is becoming high in recent years.
- the present invention was made in view of the above-described problems in conventional art, and aimed to provide a less stringiness thickener consisting of a compound in high demand as a thickener for cosmetics, i.e., polyacrylic acid or a salt thereof, or PAMPS or a salt thereof, where a stringiness property of the compound was reduced.
- the present inventors have diligently studied the above-described problems. As a result, the present inventors have found that, in the polyacrylic acid or a salt thereof, or PAMPS or a salt thereof having the weight-average molecular weight of 500 thousand to 8 million, the stringiness property displayed by the compound can be significantly reduced by allowing the content of the compound having the molecular weight of 10 million or higher to be 10 mass% or less.
- the present inventors have found that the cosmetics in which the sodium polyacrylate or sodium PAMPS, having a low stringiness property, of the present invention is blended, the stringy feeling, sliminess, and stickiness are hardly felt and the spreadability is excellent, thus leading to the completion of the present invention.
- the present invention provides a less stringiness thickener consisting of a polymer having a weight-average molecular weight between 500 thousand and 8 million, wherein said polymer contains not more than 10% by mass of the same having the molecular weight of 10 million or higher, and said polymer is selected from the group consisting of polyacrylic acid, a salt of polyacrylic acid, PAMPS, and a salt of PAMPS.
- the present invention also provides a cosmetic raw material including a less stringiness thickener consisting of a polymer having a weight-average molecular weight between 500 thousand and 8 million, wherein said polymer contains not more than 10% by mass of the same having the molecular weight of 10 million or higher, and said polymer is selected from the group consisting of polyacrylic acid, a salt of polyacrylic acid, PAMPS, and a salt of PAMPS.
- a cosmetic raw material including a less stringiness thickener consisting of a polymer having a weight-average molecular weight between 500 thousand and 8 million, wherein said polymer contains not more than 10% by mass of the same having the molecular weight of 10 million or higher, and said polymer is selected from the group consisting of polyacrylic acid, a salt of polyacrylic acid, PAMPS, and a salt of PAMPS.
- the present invention provides a cosmetic including a less stringiness thickener consisting of a polymer having a weight-average molecular weight between 500 thousand and 8 million, wherein said polymer contains not more than 10% by mass of the same having the molecular weight of 10 million or higher, and said polymer is selected from the group consisting of polyacrylic acid, a salt of polyacrylic acid, PAMPS, and a salt of PAMPS.
- a less stringiness thickener consisting of polyacrylic acid or a salt thereof, or PAMPS or a salt thereof, which has a low stringiness property, generates almost no stringy feeling, sliminess, and stickiness, and is excellent in spreadability, can be obtained.
- the cosmetics that are improved in the stringy feeling, sliminess, and stickiness and excellent in spreadability can be prepared by using this less stringiness thickener.
- FIG.1 A chart of gel permeation chromatography (GPC) analysis of the sodium polyacrylate in the present invention (Precision-synthesized sodium polyacrylate-2).
- the polyacrylic acid or a salt thereof and PAMPS or a salt thereof usable in the present invention are those having the weight-average molecular weight of 300 thousand to 8 million, preferably 500 thousand to 8 million, and the content of the compound having the molecular weight of 10 million or higher being 10 mass% or less. This is because if the weight-average molecular weight is less than 300 thousand, the spreadability tends to be poor, and if the weight-average molecular weight exceeds 8 million, it becomes technically difficult to suppress the content of the compound having the molecular weight of 10 million or higher to be 10 mass% or less. As described later, if the content of the compound having the molecular weight of 10 million or higher exceeds 10 mass%, the stringiness property becomes severe, and a stringy feeling, sliminess, and the stickiness are likely generated; thus it is not desirable.
- the synthetic polymer compound of the present invention if the content of the compound having the molecular weight that is three times or higher of the weight-average molecular weight is 10 mass% or less, the stringiness property tends to be further suppressed; thus it is desirable.
- the molecular weight distribution (namely, weight-average molecular weight/ number-average molecular weight) of the synthetic polymer compound of the present invention is preferably 2.0 or lower and more preferably 1.0 to 1.8. This is because if the molecular weight distribution exceeds 2.0, the stringiness property may become prominent.
- alkali metal salts for example, sodium salt, potassium salt, magnesium salt, calcium salt, etc.
- organic amine salts for example, monoethanolamine salt, diethanolamine salt, triethanolamine salt, triisopropanolamine salt, etc.
- the salts of basic nitrogen-containing compounds such as 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, L-arginine, L-lysine, and L-alkyl taurine.
- monovalent alkali metal salts and organic amine salts are preferable, more preferably a sodium salt, potassium salt and triethanolamine salt, and most preferably a sodium salt.
- the polyacrylic acid salt or PAMPS salt indicates the compound obtained by neutralizing the polyacrylic acid or PAMPS with the above-described base (namely, the above-described alkali metals, organic amines, basic nitrogen-containing compounds, etc.) or the compound obtained by polymerizing the acrylic acid or 2-acrylamide-2-methylpropanesulfonic acid (hereinafter abbreviated as AMPS) whose acid section is beforehand neutralized with the above-described base.
- the above-described base namely, the above-described alkali metals, organic amines, basic nitrogen-containing compounds, etc.
- AMPS 2-acrylamide-2-methylpropanesulfonic acid
- acrylic acid monomers such as methacrylic acid, alkyl acrylates, alkyl methacrylates, acrylic acid esters
- acrylamide monomers such as acrylamide and dimethylacrylamide
- vinyl monomers such as vinyl alcohol, vinylpyrrolidone, vinyl acetate, carboxyvinyl, and vinyl methyl ether
- styrene, urethane, etc. are the constituent unit monomer
- copolymers and/or salts thereof consisting of two kinds or more of the monomers selected from these monomers, acrylic acid, and AMPS.
- constituent unit is an acrylic acid monomer or acrylamide monomer
- constituent unit is an acrylic acid monomer or acrylamide monomer
- macro-monomers in which polyethylene glycol, silicone-based polymer compound, etc. are added to the above-described monomer, as the side chain, can also suitably be used as the constituent unit.
- Specific compound examples include polyacrylamide, polydimethylacrylamide, polyvinyl alcohol, polyvinylpyrrolidone, polyvinylmethyl ether, polyvinyl acetate, carboxyvinyl polymer, etc.; and (acrylic acid/alkyl acrylate) copolymer, (acrylic acid/alkyl methacrylate) copolymer, (alkyl acrylate/styrene) copolymer, polyacrylic acid ester copolymer, (dimethylacrylamide/2-acrylamido-2-methylpropanesulfonic acid) copolymer and salts thereof.
- the synthetic polymer compound of the present invention can be synthesized by a publicly known living polymerization method.
- living polymerization include living anionic polymerization, living cationic polymerization, living radical polymerization (precise radical polymerization, or controlled radical polymerization), etc.
- Examples of living radical polymerization include (radical) polymerization that is mediated by nitroxide, or nitroxide-mediated (radical) polymerization (NLRP), atom transfer radical polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT) polymerization, etc.
- Examples of atom transfer radical polymerization (ATRP) include electron transfer generated activator ATRP, or activators generated by electron transfer ATRP (AGET ATRP), electron transfer regenerated activator ATRP, or activators regenerated by electron transfer ATRP (ARGET ATRP), initiators to continuously regenerate active species ATRP, or initiators for continuous activator regeneration ATRP (ICAR ATRP), and reverse ATRP (Reverse ATRP).
- RAFT reversible addition-fragmentation chain transfer
- living radical polymerization in which organic tellurium is the growing end or organic tellurium-mediated living radical polymerization (TERP), antimony-mediated living radical polymerization (SBRP), and bismuth-mediated living radical polymerization (BIRP) can be listed.
- examples of other living radical polymerizations include iodine transfer radical polymerization (IRP), cobalt-mediated radical polymerization (CMRP), etc.
- the direct polymerization of acrylic acid is preferable because of the simplicity of polymerization.
- protected acrylic acid esters such as t-butyl acrylate, methoxymethyl acrylate, and methyl acrylate are used, and the desired polymer compound can be obtained by the succeeding deprotection.
- the reversible addition-fragmentation chain transfer polymerization method (RAFT polymerization method) is preferable because the precision synthesis (namely, the synthesis of polymer compounds with narrow molecular weight distribution) is possible (PTL 4).
- Preferable chain transfer agents are of dithio-type and trithio-type.
- a polymerization initiator that has a similar chemical structure as that of the chain transfer agent is preferable, and an azo initiator is preferable.
- the polymerization solvent is not limited in particular, and those having high solubility of monomers and polymers are suitably selected.
- the polymerization time is preferably several hours to 50 hours.
- the molecular weight of the polymer compound synthesized by the method of the present invention can be measured by publicly known methods, such as a light scattering method, an ultracentrifugal method, and a chromatographic method, for the weight-average molecular weight; and an osmometric method and a chromatographic method, for the number-average molecular weight.
- the chromatographic method is preferable because the weight-average molecular weight, the number-average molecular weight, and the molecular weight distribution can easily be obtained with a small amount of sample; in particular, a gel permeation chromatographic method (hereinafter abbreviated as GPC) is preferable.
- GPC gel permeation chromatographic method
- the molecular weight distribution used in this application is the value determined by dividing the weight-average molecular weight obtained by GPC analysis by the number-average molecular weight.
- Polyacrylic acid or a salt thereof, and PAMPS or a salt thereof of the present invention can be blended into various cosmetics as a less stringiness thickener or as a cosmetic raw material with low stringiness property.
- the most preferable blending method is the substitution of the commercial polyacrylic acid or a salt thereof, or PAMPS or a salt thereof whose molecular weight is not suitably controlled.
- unpleasant usability such as a stringy feeling, sliminess, stickiness, and poor spreadability, of the cosmetics containing the above-described commercial products, can be improved.
- the synthetic polymer compound of the present invention has a low stringiness property, and the above-described unpleasant usability is not present; therefore, more material can be blended than the corresponding commercial product.
- the polyacrylic acid or a salt thereof and PAMPS or a salt thereof of the present invention can be suitably blended as a substitute for the thickener of other compounds whose molecular weight is not controlled.
- the polyacrylic acid or a salt thereof and PAMPS or a salt thereof of the present invention can be blended, as a guide, preferably 0.01 to 5.0 mass% with respect to the total cosmetic, and more preferably 0.05 to 2.5 mass%.
- the polyacrylic acid or a salt thereof and PAMPS or a salt thereof of the present invention can be suitably blended in makeup cosmetics such as foundation, eyeshadow, eyeliner, mascara, eyebrow, lip liner, and pre-makeup; and skin care cosmetics such as cream, milky lotion, lotion, gel, pack, and mask.
- makeup cosmetics such as foundation, eyeshadow, eyeliner, mascara, eyebrow, lip liner, and pre-makeup
- skin care cosmetics such as cream, milky lotion, lotion, gel, pack, and mask.
- the present invention is described below in more detail with reference to examples, however, the scope of the present invention is not limited threto.
- the weight average molecular weight and the number average molecular weight of a polymer compound are sometimes referred to as Mw and Mn, respectively.
- RAFT polymerization method which is a living radical polymerization
- six kinds of sodium polyacrylate with different weight-average molecular weights and four kinds of sodium PAMPS with different weight-average molecular weights were precision-synthesized.
- Detailed procedures are shown below.
- 4,4'-azobis-(4-cyanovaleric acid) V-501, manufactured by Wako Pure Chemical Industries, Ltd.
- 4-cyanopentanoic acid dithiobenzoate (synthesized according to NPL 1, hereinafter abbreviated as CPD) was used as the chain transfer agent.
- ⁇ -(methyltrithiocarbonate)-S-phenylacetic acid (synthesized according to NPL 2, normally abbreviated as MTPA) may also be used.
- Acrylic acid (2504 mg), methylenebisacrylamide (38.4 ⁇ g), and V-501 (0.68 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 mL) in which CPD (0.68 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60 °C for 24 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for neutralizing the pH completely, and then the mixture was dialyzed against purified water for 4 days. Precision-synthesized sodium polyacrylate-2 (1.71 g, yield: 68%) was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 6.33 million, and the molecular weight distribution was 1.4.
- Acrylic acid (2514 mg), methylenebisacrylamide (9.6 ⁇ g), and V-501 (0.17 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 mL) in which CPD (0.17 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60 °C for 24 hours. After the polymerization reaction, sodium hydroxide aqueous solution was added for neutralizing the pH completely, and then the mixture was dialyzed against purified water for 4 days. Precision-synthesized sodium polyacrylate-3 (1.99 g, yield: 79%) was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 3.26 million, and the molecular weight distribution was 1.7.
- AMPS (2500 mg), the pH of which had been adjusted to 7.0 by sodium hydroxide, and V-501 (0.84 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 mL) in which CPD (0.17 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60 °C for 24 hours. After the polymerization reaction, the mixture was dialyzed against purified water for 4 days. Precision-synthesized sodium PAMPS-1 was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 4.03 million, and the molecular weight distribution was 1.4.
- AMPS (2510 mg), the pH of which had been adjusted to 7.0 by sodium hydroxide, and V-501 (0.70 mg) were dissolved in ion-exchanged water (9 mL), a methanol solution (1 mL) in which CPD (0.70 mg) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 60 °C for 24 hours. After the polymerization reaction, the mixture was dialyzed against purified water for 4 days. Precision-synthesized sodium PAMPS-2 was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 2.24 million, and the molecular weight distribution was 1.2.
- AMPS (9.98 g), the pH of which had been adjusted to 6.0 by sodium hydroxide, and V-501 (0.001 g) were dissolved in ion-exchanged water (40 mL), a methanol solution (3.78 mL) in which CPD (0.027 g) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 70 °C for 16 hours. After the polymerization reaction, the mixture was dialyzed against purified water for 2 days. Precision-synthesized sodium PAMPS-3 (8.5 g, yield: 85.1%) was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 13 thousand, and the molecular weight distribution was 1.4.
- AMPS (9.98 g), the pH of which had been adjusted to 6.0 by sodium hydroxide, and V-501 (0.01 g) were dissolved in ion-exchanged water (40 mL), a methanol solution (3.78 mL) in which CPD (0.27 g) had been dissolved was added, and a polymerization reaction was carried out under an argon atmosphere at 70 °C for 16 hours. After the polymerization reaction, the mixture was dialyzed against purified water for 2 days. Precision-synthesized sodium PAMPS-4 (9.2 g, yield: 92.9%) was collected by freeze-drying. As a result of GPC analysis, the weight-average molecular weight was 1.5 thousand, and the molecular weight distribution was 1.1.
- the polyacrylic acid and PAMPS sodium which were precision-synthesized by the above-described methods, were filtered through a pre-filter (DISMIC-13HP PTFE filter, pore size 0.45 ⁇ m, manufactured by Advantec Co., Ltd.). Then, GPC analysis was carried out to measure the molecular weight of those compounds.
- Example 2 Molecular weight distribution of precision-synthesized sodium polyacrylate and sodium PAMPS
- the elution peak obtained in the GPC analysis of the above-described precision-synthesized sodium polyacrylate-2 is shown in Fig. 1 .
- the weight-average molecular weight is 6.33 ⁇ 10 6
- the number-average molecular weight is 4.37 6 ⁇ 10 6 ; therefore, the molecular weight distribution (weight-average molecular weight/number-average molecular weight) is 1.4.
- the precision-synthesized sodium polyacrylate-2 synthesized by the method of the present invention is seen to be a uniform molecular weight compound.
- the weight-average molecular weight for the commercially available polyacrylic acid or a salt thereof and PAMPS or a salt thereof for cosmetics can be known as the product information; however, the molecular weight distribution is often unknown. Therefore, the filtration was attempted for the above-described commercial product with the above-described prefilter (pore size: 0.45 ⁇ m). However, the filtration could not be carried out in all cases because of clogging; thus GPC analysis could not be carried out.
- the filtration with a prefilter having a pore size of 0.45 ⁇ m is an operation that is normally carried out to remove macromolecules whose analysis is not possible by GPC.
- the present inventors have confirmed that 10 mass% solution of a linear water-soluble polymer compound with the weight-average molecular weight of about 10 million can be filtered with such a prefilter.
- more than 10 mass% of macromolecules with the molecular weight of 10 million or higher are contained in the commercial sodium polyacrylate and sodium PAMPS used in this application.
- the polymer compounds used in this analysis are as follows.
- all the commercial sodium polyacrylates are considered to contain 10 mass% or more of macromolecules with the molecular weight of 10 million or higher.
- the weight-average molecular weight is 1 million to 3 million
- at least more than 10 mass% of the compound with the molecular weight that is three times or higher of the weight-average molecular weight is considered to be contained.
- many of commercial polyacrylic acids and salts thereof, which are widely used as the thickener for cosmetics are collections of those with non-uniform molecular weights and containing a large amount of compounds having significantly larger molecular weights than the weight-average molecular weight.
- the molecular weight distribution of precision-synthesized sodium polyacrylates (Test Examples 11 to 16) prepared in this application was 1.1 to 2.0 and it was narrow in the range of the weight-average molecular weight of 20 thousand to 7.3 million, and the content of macromolecules with molecular weights of 10 million or higher was 9.2 mass% or less.
- the content of the compound with the molecular weight of three times or higher or one third or lower of the weight-average molecular weight were 5.1 mass% or less, or 14.3 mass% or less, respectively. From these, the sodium polyacrylate prepared by the method of the present invention is seen to be a collection of those with uniform molecular weights. [Tab.
- Test Example Sample Weight average molecular weight (Mw) Molecular weight distribution (Mw/Mn) Content of the compound having the following molecular weight ⁇ 1000 ⁇ 3 x Mw ⁇ 2xMw ⁇ 1 ⁇ 2 x Mw ⁇ 1 ⁇ 3 x Mw 17
- Mw/Mn Molecular weight distribution
- the molecular weight distribution of the precision-synthesized sodium PAMPS in this application was 1.1 to 1.4 and it was narrow in the range of the weight-average molecular weight of 15 thousand to 4.03 million.
- the content of macromolecules with the molecular weight of 10 million or higher was 3.6 mass% or less
- the content of the compound with the molecular weight that is three times or higher of the weight-average molecular weight was 7.7 mass% or less
- the content of the compound with the molecular weight that is one third or lower of the weight-average molecular weight was 11.2 mass% or less (Table 3).
- One mass% solution of each polymer compound was prepared and placed in a container at room temperature.
- the container was set on a texture analyzer (TA.XT Plus, manufactured by Stable Micro Systems), a round disk with the diameter of about 1 cm was uniformly and lightly contacted on the surface of the above-described solution, and the stringiness behavior of the solution was observed by letting down the container at the velocity of 5 mm/sec.
- the distance that the container descended, till the cut of the stringiness solution, was measured as the "stringiness length".
- This stringiness length is the indicator of the stringiness property of polymer compounds, and "the larger the value, the stronger the stringiness property" (PTL 5). In this application, when the stringiness length was 10 mm or less, the stringiness property was judged to be low.
- compositions 1 and 2 were prepared, and the actual application tests were carried out by three expert panelists. They were asked to apply the composition 1 on the right face and the composition 2 on the left face and asked to evaluate the below-described usabilities, according to the criteria below, of the composition 1 by comparing with the composition 2.
- Composition 1 A composition containing a polymer compound Polymer compound 0.1 mass g Glycerin 15.0 mass g Purified water 84.9 mass g
- Composition 2 A composition containing no polymer compound Glycerin 15.0 mass g Purified water 85.0 mass g
- the stringiness property of all the precision-synthesized sodium polyacrylates of the present invention is low (stringiness length: 10 mm or less). Even when the composition containing 0.1 mass% thereof is applied on the skin, the stringy feeling and sliminess were hardly felt (Test Examples 11 to 16). As described above, the stringiness property of polymer compounds is dependent on viscosity; thus the stringiness property is generally considered to increase with the increase in the weight-average molecular weight.
- the precision-synthesized sodium polyacrylate-4 (Test Example 14) hardly contains the compound with the weight-average molecular weight of 10 million or higher, and it is a compound with very uniform molecular weights.
- the commercial polyacrylic acid-1 (Test Example 1) with the weight-average molecular weight of 10 million or higher was added in equal masses.
- a high-stringiness compound that displays a stringiness length that is close to the average of those of Test Example 14 and Test Example 1 (stringiness length: 12 mm) was obtained (Test Example 7). This mixture generated a stringy feeling, sliminess, and also stickiness.
- the stringiness property, stringy feeling, sliminess, and stickiness are considered to be suppressible, for the polyacrylic acid and a salt thereof with the weight-average molecular weight of 8 million or less, by suppressing the content of macromolecules with molecular weights of 10 million or higher to be 10 mass% or less.
- the stringiness property is low, a stringy feeling, sliminess, and stickiness are hardly observed, and the spreadability is also excellent if the content of the macromolecule with the molecular weight of 10 million or higher is 10 mass% or less.
- the polyacrylic acid or a salt thereof and PAMPS or a salt thereof of the present invention can be suitably used in cosmetics as the cosmetic raw material and preferably as the less-stringiness thickener, where the stringiness property is low and a stringy feeling, sliminess, and stickiness are not present.
- Components (6) and (15) were dissolved in component (4), and the resulting mixture is referred to as A.
- Component (14) was dissolved in component (3), and the resulting mixture is referred to as B.
- the mixture A and B were dissolved in component (16) in which the remaining components had been dissolved, to obtain a lotion.
- Components (8), (9), and (14) were dissolved in component (7), and the resulting mixture is referred to as A.
- Components (12) was dissolved in a mixture of components (3) and (4), and the resulting mixture is referred to as B.
- Components (2), (5), (6), (10), (11), and (13) were dissolved in component (15), and the resulting mixture was stirred with a homomixer while the mixture A, B, and component (1) were added thereto. The resulting mixture was mixed and emulsified to obtain a serum.
- Components (2) - (6), (9) - (11) were heating dissolved to form A.
- Component (17) was dissolved in component (8), and the resulting mixture is referred to as B.
- Components (12) - (15), (18) - (19) were dissolved in component (20), and the resulting mixture was heated and stirred with a homomixer while the mixture A and B were added thereto.
- component (1) was added and mixed to be emulsified. After that, the resulting mixture was cooled and then component (16) was added thereto to obtain a milk.
- Components (2) - (6), (9) - (11) were heating dissolved to form A.
- Component (17) was dissolved in component (8), and the resulting mixture is referred to as B.
- Components (7), (12) - (15), (18) - (19) were dissolved in component (20), and the resulting mixture was heated and stirred with a homomixer while the mixture A and B were added thereto.
- component (1) was further added and mixed to be emulsified. After that, the resulting mixture was cooled and then component (16) was added thereto to obtain a milk.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2013/077521 WO2015052804A1 (fr) | 2013-10-09 | 2013-10-09 | Épaississant à faible pouvoir filant et substance cosmétique mélangée avec ledit épaississant |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3056194A1 true EP3056194A1 (fr) | 2016-08-17 |
EP3056194A4 EP3056194A4 (fr) | 2017-07-19 |
EP3056194B1 EP3056194B1 (fr) | 2020-08-19 |
Family
ID=52812651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13895394.8A Active EP3056194B1 (fr) | 2013-10-09 | 2013-10-09 | Épaississant à faible pouvoir filant et substance cosmétique mélangée avec ledit épaississant |
Country Status (8)
Country | Link |
---|---|
US (2) | US20160250131A1 (fr) |
EP (1) | EP3056194B1 (fr) |
JP (1) | JP6503296B2 (fr) |
KR (1) | KR102151836B1 (fr) |
CN (2) | CN105792811B (fr) |
HK (1) | HK1222327A1 (fr) |
SG (1) | SG11201602781QA (fr) |
WO (1) | WO2015052804A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112672729A (zh) * | 2018-09-14 | 2021-04-16 | 株式会社资生堂 | 油包水型乳化化妆品 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7260484B2 (ja) * | 2017-12-28 | 2023-04-18 | 株式会社 資生堂 | 化粧料 |
TW202034890A (zh) * | 2018-09-14 | 2020-10-01 | 日商資生堂股份有限公司 | 油中水型皮膚外用組成物 |
JP6634496B2 (ja) * | 2018-10-30 | 2020-01-22 | 株式会社 資生堂 | 低曳糸性増粘剤、及び該増粘剤を配合した化粧料 |
WO2020218176A1 (fr) * | 2019-04-24 | 2020-10-29 | 株式会社 資生堂 | Matière première cosmétique |
KR20210000456A (ko) | 2019-06-25 | 2021-01-05 | (주)씨엔엔티 | 나노셀룰로오스 기반의 화장료용 천연증점제 제조 방법 및 이에 의해 제조된 나노셀룰로오스 기반의 화장료용 천연증점제 |
CN115243662A (zh) * | 2020-03-09 | 2022-10-25 | 株式会社资生堂 | 清洗剂 |
WO2021215211A1 (fr) * | 2020-04-24 | 2021-10-28 | 株式会社 資生堂 | Produit cosmétique |
CN116367815A (zh) * | 2020-08-28 | 2023-06-30 | 科罗拉多大学董事会法人团体 | 用于皮内使用的紫外吸收纳米颗粒和微颗粒 |
JPWO2022085562A1 (fr) | 2020-10-21 | 2022-04-28 | ||
CN117999060A (zh) * | 2021-10-13 | 2024-05-07 | 株式会社资生堂 | 化妆品 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4065422A (en) * | 1977-02-16 | 1977-12-27 | General Mills Chemicals, Inc. | High slip polymer composition containing a polyacrylamido sulfonic acid salt and an alcohol |
US5221722A (en) * | 1988-11-28 | 1993-06-22 | The B. F. Goodrich Company | Crosslinked polyacrylic acid |
DE69029804T2 (de) * | 1989-06-07 | 1997-09-04 | Gail S Bazzano | VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL |
JPH0586361A (ja) * | 1991-03-06 | 1993-04-06 | Sanyo Chem Ind Ltd | ゲル状保冷材 |
JP3557044B2 (ja) | 1995-06-29 | 2004-08-25 | 株式会社資生堂 | 皮膚柔軟化剤 |
JPH1045546A (ja) * | 1996-04-26 | 1998-02-17 | Shiseido Co Ltd | 整髪料 |
JPH1017635A (ja) | 1996-07-08 | 1998-01-20 | Japan Synthetic Rubber Co Ltd | 注型重合用放射線硬化性樹脂組成物 |
JP2005145982A (ja) * | 1999-05-12 | 2005-06-09 | Kao Corp | 角栓除去剤 |
JP3531735B2 (ja) * | 2000-01-11 | 2004-05-31 | 株式会社資生堂 | 増粘剤の製造方法および化粧料 |
US6986895B2 (en) * | 2001-09-12 | 2006-01-17 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Thickened cosmetic compositions |
ATE323462T1 (de) * | 2002-01-04 | 2006-05-15 | Oreal | Ein silikon-copolymer und entweder ein polymer aus einem ethylenisch ungesättigten monomer mit sulfongruppen oder ein organisches pulver enthaltende zusammensetzung; deren verwendungen, insbesondere in der kosmetik |
US7449439B2 (en) * | 2002-10-04 | 2008-11-11 | Toagosei Co., Ltd. | Water-soluble thickener and liquid acidic detergent |
JP2005160890A (ja) * | 2003-12-05 | 2005-06-23 | Toyo Ink Mfg Co Ltd | 生体用粘着ゲルシート |
FR2867070B1 (fr) * | 2004-03-04 | 2009-07-10 | Oreal | Gel autobronzant transparent contenant un polymere d'acide acrylamido 2-methyl propane sulfonique hydrosoluble ou hydrodispersible |
US9572754B2 (en) * | 2004-03-04 | 2017-02-21 | L'oreal | Transparent self-tanning gels containing a water-soluble/dispersible acrylamido-2-methylpropanesulfonic acid polymer |
JP3728528B2 (ja) | 2004-03-25 | 2005-12-21 | 財団法人北九州産業学術推進機構 | 曳糸性測定装置 |
JP5076428B2 (ja) * | 2006-10-02 | 2012-11-21 | 東亞合成株式会社 | ポリ(メタ)アクリル酸部分中和物の粉末を含むパップ剤 |
JP4714241B2 (ja) * | 2008-05-30 | 2011-06-29 | 株式会社 資生堂 | 水中油型皮膚外用剤 |
EP2182011A1 (fr) * | 2008-10-29 | 2010-05-05 | Basf Se | Procédé de préparation de solutions aqueuses d'acide polyacrylique par polymerisation radicalaire contrôlée |
JP5391824B2 (ja) * | 2009-05-19 | 2014-01-15 | 東亞合成株式会社 | 水系増粘剤及びその製造方法並びにそれを用いた水性増粘液 |
JP2011002418A (ja) | 2009-06-22 | 2011-01-06 | Mandom Corp | 曳糸性の評価方法 |
JP2013043843A (ja) * | 2011-08-23 | 2013-03-04 | Eki Nakagawa | 静電容量式タッチパネル操作用塗布剤及び静電容量式タッチパネル操作用手袋 |
US8815783B2 (en) * | 2011-12-20 | 2014-08-26 | Halliburton Energy Services, Inc. | High molecular weight low polydispersity polymers |
JP5952592B2 (ja) | 2012-03-02 | 2016-07-13 | 花王株式会社 | 粘性化粧料 |
CN102633700A (zh) * | 2012-03-31 | 2012-08-15 | 天津大学 | 水溶性raft链转移剂的制备及低分子量聚丙烯酸的合成方法 |
-
2013
- 2013-10-09 KR KR1020167005050A patent/KR102151836B1/ko active IP Right Grant
- 2013-10-09 SG SG11201602781QA patent/SG11201602781QA/en unknown
- 2013-10-09 EP EP13895394.8A patent/EP3056194B1/fr active Active
- 2013-10-09 CN CN201380080151.6A patent/CN105792811B/zh active Active
- 2013-10-09 CN CN202110361568.6A patent/CN113288824A/zh active Pending
- 2013-10-09 WO PCT/JP2013/077521 patent/WO2015052804A1/fr active Application Filing
- 2013-10-09 JP JP2015541373A patent/JP6503296B2/ja active Active
- 2013-10-09 US US15/028,134 patent/US20160250131A1/en not_active Abandoned
-
2016
- 2016-09-05 HK HK16110523.7A patent/HK1222327A1/zh unknown
-
2017
- 2017-10-16 US US15/784,337 patent/US11439582B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112672729A (zh) * | 2018-09-14 | 2021-04-16 | 株式会社资生堂 | 油包水型乳化化妆品 |
EP3854378A4 (fr) * | 2018-09-14 | 2022-07-20 | Shiseido Company, Ltd. | Composition cosmétique en émulsion eau dans l'huile |
Also Published As
Publication number | Publication date |
---|---|
US20160250131A1 (en) | 2016-09-01 |
SG11201602781QA (en) | 2016-05-30 |
CN105792811B (zh) | 2021-09-10 |
KR20160056878A (ko) | 2016-05-20 |
JP6503296B2 (ja) | 2019-04-17 |
CN105792811A (zh) | 2016-07-20 |
WO2015052804A1 (fr) | 2015-04-16 |
CN113288824A (zh) | 2021-08-24 |
US11439582B2 (en) | 2022-09-13 |
EP3056194A4 (fr) | 2017-07-19 |
EP3056194B1 (fr) | 2020-08-19 |
US20180036221A1 (en) | 2018-02-08 |
KR102151836B1 (ko) | 2020-09-03 |
HK1222327A1 (zh) | 2017-06-30 |
JPWO2015052804A1 (ja) | 2017-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11439582B2 (en) | Low-stringiness thickener and cosmetic material admixed with said thickener | |
EP3235839B1 (fr) | Copolymère et agent gélifiant huileux | |
EP2611412B2 (fr) | Copolymeres acryliques reticules | |
US20120164092A1 (en) | Hair Styling Cosmetic Composition | |
EP2106784B1 (fr) | Composition de coiffage | |
EP2433614A2 (fr) | Compositions de coiffage de turbidité réduite et plus résistantes à l'humidité | |
CN102046145B (zh) | 毛发类化妆品 | |
CN111526867B (zh) | 化妆品 | |
EP2039344A2 (fr) | Composition cosmétique comprenant un copolymère cationique et un polymère associatif anionique et procédé de traitement cosmétique | |
CN103189404A (zh) | 共聚物及化妆品用组合物 | |
JP6634496B2 (ja) | 低曳糸性増粘剤、及び該増粘剤を配合した化粧料 | |
KR20120046305A (ko) | 정발용 화장료 | |
JP4312122B2 (ja) | 化粧料 | |
TWI649094B (zh) | 低曳絲增黏劑,及含有該增黏劑之配方之化粧料 | |
JP6284777B2 (ja) | 毛髪化粧料 | |
JP2006045439A (ja) | 新規共重合体及びこれを配合する化粧料 | |
KR20130071517A (ko) | 초임계 유체를 이용한 무용제형 아크릴산 단량체와 포스포릴콜린 유사기 함유 단량체 기반의 가교 결합 공중합체의 제조방법 및 이를 포함하는 화장료 조성물 | |
JP2005179326A (ja) | 化粧料 | |
JP2015124200A (ja) | 毛髪化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160411 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170616 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08F 120/58 20060101ALI20170609BHEP Ipc: C09K 3/00 20060101ALI20170609BHEP Ipc: A61Q 19/00 20060101ALI20170609BHEP Ipc: A61K 8/81 20060101AFI20170609BHEP Ipc: C08F 8/44 20060101ALI20170609BHEP Ipc: C08F 120/06 20060101ALI20170609BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180730 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/81 20060101AFI20200221BHEP Ipc: C08F 120/06 20060101ALI20200221BHEP Ipc: C08F 120/58 20060101ALI20200221BHEP Ipc: A61Q 19/00 20060101ALI20200221BHEP |
|
INTG | Intention to grant announced |
Effective date: 20200323 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SHISEIDO COMPANY, LTD. |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013071881 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1303135 Country of ref document: AT Kind code of ref document: T Effective date: 20200915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201221 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201120 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1303135 Country of ref document: AT Kind code of ref document: T Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201219 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013071881 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201009 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20201031 |
|
26N | No opposition filed |
Effective date: 20210520 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230516 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230920 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230920 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230920 Year of fee payment: 11 |